These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Filed by the Registrant x |
|
Filed by a Party other than the Registrant ¨ |
¨ |
|
Preliminary Proxy Statement |
¨ |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
x |
|
Definitive Proxy Statement |
¨ |
|
Definitive Additional Materials |
¨ |
|
Soliciting Material Pursuant to §240.14a-12 |
Payment of Filing Fee (Check the appropriate box): |
x |
No fee required. |
¨ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) |
Title of each class of securities to which transaction applies: |
(2) |
Aggregate number of securities to which transaction applies:
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
(4) |
Proposed maximum aggregate value of transaction:
|
(5) |
Total fee paid:
|
¨ |
Fee paid previously with preliminary materials. |
¨ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) |
Amount previously paid:
|
(2) |
Form, Schedule or Registration Statement No.:
|
(3) |
Filing Party:
|
(4) |
Date Filed:
|
Sincerely, |
![]() |
MICHAEL F. NEIDORFF |
Chairman, President and Chief Executive Officer |
Time and Date |
|
10:00 A.M., central daylight savings time, on Tuesday, April 27, 2010 |
Place |
|
The Ritz-Carlton
100 Carondelet Avenue
St. Louis, Missouri 63105
Amphitheatre |
Items of Business |
|
At the meeting, we will ask you and our other stockholders to consider and act upon the following matters: |
|
(1) to elect two Class III directors to three-year terms; | |
|
(2) to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2010; | |
|
(3) approve amendments to the 2003 Stock Incentive Plan to increase the number of shares of common stock reserved for issuance under the plan by 2,150,000, from 6,900,000 to 9,050,000; | |
(4) to transact any other business properly presented at the meeting. | ||
Record Date |
|
You may vote if you were a stockholder of record at the close of business on February 26, 2010. |
Proxy Voting |
|
It is important that your shares be represented and voted at the meeting. Whether or not you plan to attend the meeting, please vote by internet, telephone or mail. You may revoke your proxy at any time before its exercise at the meeting. Please reference the proxy notice for additional information. |
Stockholder List |
|
A list of stockholders entitled to vote will be available at the meeting. In addition, you may contact our Secretary, Keith H. Williamson, at our address as set forth in the notice appearing before this proxy statement, to make arrangements to review a copy of the stockholder list at our offices located at 7711 Carondelet Avenue, St. Louis,
Missouri, before the meeting, between the hours of 8:00 A.M. and 5:00 P.M., central daylight savings time, on any business day from April 13, 2010, up to one hour prior to the time of the meeting. |
Attending the Annual Meeting |
|
If you would like to attend the meeting, please bring evidence to the meeting that you own common stock, such as a stock certificate, or, if your shares are held by a broker, bank or other nominee, please bring a recent brokerage statement or a letter from the nominee confirming your beneficial ownership of such shares. You must also bring
a form of personal identification. |
By order of the board of directors, |
![]() |
Keith H. Williamson
Secretary |
INFORMATION ABOUT THE MEETING | ||
|
1 | |
|
1 | |
|
1 | |
|
2 | |
|
2 | |
|
2 | |
DISCUSSION OF PROPOSALS | ||
|
3 | |
|
4 | |
4 | ||
|
10 | |
|
10 | |
INFORMATION ABOUT CONTINUING DIRECTORS AND EXECUTIVE OFFICERS | ||
|
11 | |
|
12 | |
INFORMATION ABOUT CORPORATE GOVERNANCE | ||
|
15 | |
|
15 | |
|
18 | |
|
19 | |
|
19 | |
|
19 | |
|
20 | |
|
20 | |
|
21 | |
|
22 | |
|
22 | |
INFORMATION ABOUT EXECUTIVE COMPENSATION | ||
|
22 | |
|
22 | |
|
32 | |
|
33 | |
|
34 | |
|
35 | |
|
35 | |
|
36 | |
|
37 | |
|
39 | |
OTHER MATTERS | ||
|
40 | |
|
42 | |
|
42 | |
A-1 |
• |
THIS PROXY STATEMENT summarizes information about the proposals to be considered at the meeting and other information you may find useful in determining how to vote. |
• |
THE PROXY CARD is the means by which you actually authorize another person to vote your shares in accordance with the instructions. |
• |
TO VOTE IN PERSON, you must attend the meeting, and then complete and submit the ballot provided at the meeting. If your shares are held in the name of a bank, broker or other nominee holder, you will receive instructions from the holder of record explaining how your shares may be voted.
Please note that, in such an event, you must obtain a proxy, executed in your favor, from the holder of record to be able to vote at the meeting. |
• |
TO VOTE BY PROXY, you must follow the instructions on the proxy notice and then vote by means of the internet, telephone or, if you received your proxy materials by mail, mailing the proxy card in the enclosed postage-paid envelope. Your proxy will be valid only if you vote before the
meeting. By voting, you will direct the designated persons to vote your shares at the meeting in the manner you specify. If, after requesting paper materials, you complete the proxy card with the exception of the voting instructions, then the designated persons will vote your shares in accordance with the instructions contained therein, and if no choice is specified, such proxies will be voted in favor of the |
|
matters set forth in the accompanying Notice of Annual Meeting. If any other business properly comes before the meeting, the designated persons will have the discretion to vote your shares as they deem appropriate. |
• |
send written notice to Keith H. Williamson, our Secretary, at our address as set forth in the notice appearing before this proxy statement; |
• |
submit a new vote by means of the internet or telephone; or |
• |
attend the meeting, notify our Secretary that you are present, and then vote by ballot. |
|
Class III Directors | |||
Pamela A. Joseph |
Ms. Joseph has been a director since September 2007. Ms. Joseph has served as Vice Chairman of U.S. Bancorp and Chairman and Chief Executive Officer of NOVA Information Systems, Inc. since 2004. From 2000 to 2004, Ms. Joseph served as President and Chief Operating Officer for NOVA Information Systems, Inc. She
also serves as a director for Paychex Inc., a payroll, human resource, and employee benefit outsourcing solution for small to medium sized businesses. Ms. Joseph’s range of experiences include, in particular, experience as a chief executive officer, as well as technology and service industry expertise. Ms. Joseph is 51 years old. |
|||
Tommy G. Thompson |
|
Mr. Thompson has been a director since April 2005. Mr. Thompson is a partner in the law firm of Akin Gump Strauss Hauer & Feld LLP in Washington, D.C.; and is President of Logistics Health, Inc., a provider of medical readiness and homeland security solutions. From March 2005 to
May 2009, Mr. Thompson also worked for the consulting practice of Deloitte and Touche USA LLP. From 2001 to January 2005, Mr. Thompson served as secretary of U.S. Department of Health & Human Services. From 1987 to 2001, Mr. Thompson served as Governor of the State of Wisconsin. He also serves as a director for AGA Medical Corporation, a designer, manufacturer and distributor of medical devices; C.R. Bard, Inc., a designer, manufacturer, and distributor of medical, surgical, diagnostic, and patient care devices;
CareView Communications, a company that has designed patient monitoring equipment for use in hospitals; and, United Therapeutics, a biotechnology company that develops and distributes medical products. Mr. Thompson currently is taking a leave of absence as a director from CNS Response, a company that has designed software to improve the treatment of behavioral health disorders. Mr. Thompson previously served as a director for Pure Bioscience, a manufacturer and marketer of technology-based bioscience
products; and SpectraScience Inc., a designer and manufacturer of medical devices. Mr. Thompson’s range of experiences include, in particular, experience as a chief executive officer, political and regulatory relationships and healthcare expertise. Mr. Thompson is 68 years old. |
• |
attract new employees and executives with competitive compensation packages; |
• |
retain our existing executives who are attractive candidates to other companies in our industries; |
• |
motivate and recognize our high performing individuals; and |
• |
ensure the availability of stock incentives for employees we hire as a result of acquisitions. |
• |
incentive stock options intended to qualify under Section 422 of the Internal Revenue Code; |
• |
non-statutory stock options; |
• |
restricted stock awards; and |
• |
restricted stock units, collectively referred to herein as awards; and |
• |
stock appreciation rights. |
• |
payment by cash, check or in connection with a “cashless exercise” through a broker; |
• |
surrender of shares of our common stock that have been held for at least six months; |
• |
any other lawful means (other than promissory notes); or |
• |
any combination of these forms of payment. |
Name and Position |
|
Stock Options |
|
Restricted Stock Units | ||
Michael F. Neidorff, Chairman, President and Chief Executive Officer |
— |
150,000 | ||||
William N. Scheffel, Executive Vice President and Chief Financial Officer |
— |
25,000 | ||||
Mark W. Eggert, Executive Vice President, Health Plan Business Unit |
— |
20,000 | ||||
Jason M. Harrold, Senior Vice President, Specialty Business Unit |
— |
25,000 | ||||
Jesse N. Hunter, Executive Vice President, Corporate Development |
— |
25,000 | ||||
Eric R. Slusser, Former Executive Vice President and Chief Financial Officer |
— |
— | ||||
All executive officers as a group |
— |
336,000 | ||||
All non-employee directors as a group |
— |
40,584 | ||||
Employees other than executive officers, as a group |
14,000 |
324,828 |
• |
the number of shares of our common stock covered by options and the dates upon which such options become exercisable; |
• |
the exercise price of options; |
• |
the duration of options; and |
• |
the number of shares of our common stock subject to any restricted stock or other stock-based awards and the terms and conditions of such awards, including conditions for repurchase, issue price and repurchase price, subject to the restriction on re-pricing described below. |
• |
no outstanding award granted under the 2003 Plan may be amended to provide for an exercise price per share that is less than the then-existing exercise price per share of such outstanding award, |
• |
the board may not cancel any outstanding award (whether or not granted under the 2003 Plan) and grant in substitution therefore new awards under the 2003 Plan covering the same or a different number of shares and having an exercise price per share less than the then-existing exercise price per share of the cancelled award, and |
• |
no outstanding award granted under the 2003 Plan may be repurchased by the Company at a price greater than the current fair market value of the outstanding award. |
• |
all material revisions (as defined by the applicable rules of the New York Stock Exchange) to the 2003 Plan shall be subject to stockholder approval, and |
• |
no award designated as subject to Section 162(m) of the Internal Revenue Code by the board after the date of such amendment shall become exercisable, realizable or vested (to the extent such amendment was required to grant such award) unless and until such amendment shall have been approved by our stockholders. |
|
Class I Directors | |
Michael F. Neidorff |
|
Mr. Neidorff has served as our Chairman, President and Chief Executive Officer since May 2004. From May 1996 to May 2004, Mr. Neidorff served as President, Chief Executive Officer and as a member of our board of directors. From 1995 to 1996, Mr. Neidorff served as a Regional Vice President of Coventry Corporation, a publicly-traded
managed care organization, and as the President and Chief Executive Officer of one of its subsidiaries, Group Health Plan, Inc. From 1985 to 1995, Mr. Neidorff served as the President and Chief Executive Officer of Physicians Health Plan of Greater St. Louis, a subsidiary of United Healthcare Corp., a publicly-traded managed care organization now known as UnitedHealth Group Incorporated. Mr. Neidorff also serves as a director of Brown Shoe Company, Inc., a publicly-traded footwear company with global
operations. Mr. Neidorff’s range of experiences include, in particular, experience as a chief executive officer, as well as healthcare, investment banking and organizational development expertise. Mr. Neidorff is 67 years old. |
Richard A. Gephardt |
|
Mr. Gephardt has been a director since December 2006. Mr. Gephardt is CEO and President of Gephardt Group, LLC a multi-disciplined consulting firm focused on helping clients gain access to new markets, expand competitive advantages in existing markets, manage labor negotiations, develop political strategies and promote policy initiatives. Mr.
Gephardt has served as a consultant to Goldman, Sachs & Co. since January 2005, as Senior Advisor to DLA Piper since June 2005, and as Senior Advisor to FTI since January 2007. Mr. Gephardt served as a Member of the U.S. House of Representatives from 1977 to 2005. He also serves as a director for Spirit Aerosystems, Inc., a supplier of commercial airplane assemblies and components; CenturyLink, a communication services company; Ford Motor Company, an auto manufacturer; and US Steel Corporation,
a manufacturer of a wide variety of steel sheet, tubular and tin products, coke, and taconite pellets. He previously served as a director for Dana Corporation, an auto parts manufacturer and supplier. Mr. Gephardt’s range of experiences include, in particular, political and regulatory relationships as well as investment banking and healthcare expertise. Mr. Gephardt is 69 years old. |
John R. Roberts |
|
Mr. Roberts has been a director since March 2004. Mr. Roberts served as the Executive Director of Civic Progress, Inc., a St. Louis civic organization, from 2001 to December 2006. Mr. Roberts is a retired Managing Partner, Mid-South Region, Arthur Andersen LLP. He also serves as a director and chairman of the audit |
|
|
committee of both Regions Financial Corporation, a provider of banking, brokerage, mortgage and insurance products and services, and Energizer Holdings, Inc., a manufacturer of household products. Mr. Roberts’ range of experiences include, in particular, organizational development expertise as well as experience in service
industries and public accounting. Mr. Roberts is 68 years old. |
|
Class II Directors | |
Robert K. Ditmore |
|
Mr. Ditmore has been a director since 1996. Mr. Ditmore is a retired President and Chief Operating Officer of United Healthcare Corp., a publicly traded managed care organization now known as UnitedHealth Group Incorporated. Mr. Ditmore also served as a director of UnitedHealth Group Inc. from 1985 to 1995. Mr. Ditmore’s
range of experiences include, in particular, chief executive officer roles and extensive healthcare and service industry expertise. Mr. Ditmore is 75 years old. |
Frederick H. Eppinger |
|
Mr. Eppinger has been a director since April 2006. Mr. Eppinger has served as a director and President and Chief Executive Officer of The Hanover Insurance Group, Inc., a holding company for a group of insurers that offers a wide range of property and casualty products, since 2003. From 2001 to 2003, Mr. Eppinger was Executive Vice President
of Property and Casualty Field and Service Operations for The Hartford Financial Services Group, Inc. From 2000 to 2001, he was Executive Vice President for Channel Point, Inc. From 1985 to 2000, he was in the financial institutions group at McKinsey & Company, an international management consulting firm, where he was admitted as a partner in 1992. Mr. Eppinger’s range of experiences include, in particular, chief executive officer roles, as well as organizational development and insurance
industry expertise. Mr. Eppinger is 51 years old. |
David L. Steward |
|
Mr. Steward has been a director since May 2003. Mr. Steward is the founder of World Wide Technology, Inc. and has served as its Chairman since its founding in 1990. In addition, Mr. Steward has served as Chairman of Telcobuy.com, an affiliate of World Wide Technology, Inc., since 1997. World Wide Technology, Inc. and Telcobuy.com provide electronic
procurement and logistics services to companies in the information technology and telecommunications industries. He also serves as director of First Banks, Inc., a registered bank holding company. Mr. Steward’s range of experiences include, in particular, chief executive officer roles, political and regulatory relationships, as well as technology expertise. Mr. Steward is 58 years old. |
Michael F. Neidorff |
|
Mr. Neidorff is our Chairman, President and Chief Executive Officer. You will find background information about Mr. Neidorff on page 11. |
Mark. W. Eggert |
Mr. Eggert has served as our Executive Vice President, Health Plan Business Unit since November 2007. From January 1999 to November 2007, Mr. Eggert served as the Associate Vice Chancellor and Deputy General Counsel at Washington University, where he oversaw the legal affairs of the School of Medicine. Mr. Eggert is 48
years old. | |
Carol E. Goldman |
|
Ms. Goldman has served as Executive Vice President and Chief Administrative Officer since June 2007. From July 2002 to June 2007, she served as our Senior Vice President, Chief Administrative Officer. From September 2001 to July 2002, Ms. Goldman served as our Plan Director of Human Resources. From 1998 to
August 2001, Ms. Goldman was Human Resources Manager at Mallinckrodt Inc., a medical device and pharmaceutical company. Ms. Goldman is 52 years old. |
Jason M. Harrold |
Mr. Harrold has served as our Senior Vice President, Specialty Business Unit since August 2009. He served as President of OptiCare from July 2000 to August 2009. From July 1996 to July 2000, Mr. Harrold held various positions of increasing responsibility at OptiCare including Vice President of Operations and Chief Operating
Officer. Mr. Harrold is 40 years old. | |
Jesse N. Hunter |
|
Mr. Hunter has served as our Executive Vice President, Corporate Development since April 2008. He served as our Senior Vice President, Corporate Development from April 2007 to April 2008. He served as our Vice President, Corporate Development from December 2006 to April 2007. From October 2004 to December 2006,
he served as our Vice President, Mergers & Acquisitions. From July 2003 until October 2004, he served as the Director of Mergers & Acquisitions and from February 2002 until July 2003, he served as the Manager of Mergers & Acquisitions. Mr. Hunter is 34 years old. |
Donald G. Imholz |
Mr. Imholz has served as our Executive Vice President and Chief Information Officer since December 2009. Mr. Imholz served as our Senior Vice President and Chief Information Officer from September 2008 to December 2009. From January 2008 to September 2008, Mr. Imholz was an independent consultant working for clients across
a variety of industries. From January 1975 to January 2008, Mr. Imholz was with The Boeing Company and served as Vice President of Information Technology from 2002 to January 2008. In that role, Mr. Imholz was responsible for all application development and support worldwide. Mr. Imholz is 58 years old. | |
|
Edmund E. Kroll |
|
Mr. Kroll has served as our Senior Vice President, Finance and Investor Relations since May 2007. From June 1997 to November 2006, Mr. Kroll served as Managing Director at Cowen and Company LLC, |
|
|
where his research coverage focused on the managed care industry, including the Company. Mr. Kroll is 50 years old. |
Frederick J. Manning |
Mr. Manning has served as our Executive Vice President, Celtic Insurance Company since July 2008. From 1978 to July 2008, Mr. Manning served as Chief Executive Officer and Chairman of the Board of Celtic Insurance Company. Mr. Manning is 62 years old. | |
William N. Scheffel |
|
Mr. Scheffel has served as our Executive Vice President, Chief Financial Officer and Treasurer since May 2009. He served as our Executive Vice President, Specialty Business Unit from June 2007 to May 2009. From May 2005 to June 2007, he served as our Senior Vice President, Specialty Business Unit. From December 2003 until
May 2005, he served as our Senior Vice President and Controller. From July 2002 to October 2003, Mr. Scheffel was a partner with Ernst & Young LLP. From 1975 to July 2002, Mr. Scheffel was with Arthur Andersen LLP. Mr. Scheffel is 56 years old. |
Jeffrey A. Schwaneke |
Mr. Schwaneke has served as our Vice President, Corporate Controller since July 2008 and Chief Accounting Officer since September 2008. He previously served as Vice President, Controller and Chief Accounting Officer at Novelis Inc. from October 2007 to July 2008, and Assistant Corporate Controller from May 2006 to September 2007. Mr.
Schwaneke served as Segment Controller for SPX Corporation from January 2005 to April 2006. Mr. Schwaneke served as Corporate Controller at Marley Cooling Technologies, a segment of SPX Corporation, from March 2004 to December 2004 and Director of Financial Reporting from November 2002 to February 2004. Mr. Schwaneke is 34 years old. | |
Toni Simonetti |
Ms. Simonetti has served as our Senior Vice President, Public Affairs since December 2009. She previously served as Vice President, Global Communications at GMAC Financial Services from July 2004 to June 2009. From December 1999 to September 2006, Ms. Simonetti served as Executive Director, Financial Communications and
Global Media Relations at General Motors Corporation. Ms. Simonetti is 53 years old. | |
Keith H. Williamson |
|
Mr. Williamson has served as our Senior Vice President, General Counsel since November 2006 and as our Secretary since February 2007. From 1988 until November 2006, he served at Pitney Bowes Inc. in various legal and executive roles, the last seven years as a Division President. Mr. Williamson also serves as a director
of PPL Corporation, a publicly-traded energy and utility holding company. Mr. Williamson is 57 years old. |
• |
a strong, independent, clearly-defined presiding director role | ||
• |
executive sessions of the independent directors after every board meeting | ||
• |
annual performance evaluations of the chairman and CEO by the independent directors. |
• |
appointing, retaining, evaluating, terminating, approving the compensation of, and assessing the independence of our independent registered public accounting firm; |
• |
overseeing the work of our independent auditor, including through the receipt and consideration of certain reports from the independent registered public accounting firm; |
• |
reviewing and discussing with management and the independent registered public accounting firm our annual and quarterly financial statements and related disclosures; |
• |
monitoring our internal control over financial reporting, disclosure controls and procedures and code of business conduct and ethics; |
• |
overseeing our internal audit function; |
• |
discussing our risk management policies; |
• |
establishing policies regarding hiring employees from our independent registered public accounting firm and procedures for the receipt and retention of accounting related complaints and concerns; |
• |
meeting independently with our internal auditing staff, independent registered public accounting firm and management; and |
• |
preparing the audit committee report required by SEC rules (which is included on page 20 of this proxy statement). |
· |
evaluating compensation policies and practices to determine if they may be influencing employees to take excessive risks; |
· |
annually reviewing and approving corporate goals and objectives relevant to our chief executive officer’s compensation; |
· |
reviewing and making recommendations to the board with respect to our chief executive officer’s compensation; |
· |
reviewing and approving, or making recommendations to the board with respect to, the compensation of our other executive officers; |
· |
overseeing an evaluation of our senior executives; |
· |
overseeing and administering our equity incentive plans; and |
· |
reviewing and making recommendations to the board with respect to director compensation. |
• |
identifying individuals qualified to become members of the board; |
• |
recommending to the board the persons to be nominated for election as directors and to each of the board’s committees; |
• |
reviewing and making recommendations to the board with respect to management succession planning; |
• |
reviewing and recommending to the board corporate governance principles; and |
• |
overseeing an annual evaluation of the board’s performance. |
· |
Public company governance |
· |
Healthcare |
· |
Service and insurance industry |
· |
Companies with revenues greater than $1 billion |
· |
Public accounting |
· |
Investment banking |
· |
Technology |
· |
Organizational development |
· |
Political and regulatory relationships |
· |
Experience as a chief executive officer |
|
(a) |
|
(b) |
|
(c) | ||
Plan Category |
|
Number of Securities to be Issued Upon Exercise of Outstanding Options,
Warrants and Rights |
|
Weighted-Average Exercise Price of Outstanding Options, Warrants
and Rights |
|
Number of Securities Remaining Available For Future Issuance Under
Equity Compensation Plans (Excluding Securities Reflected in Column (a)) | |
Equity compensation plans approved by stockholders |
|
5,151,816 |
|
$ |
20.31 |
|
1,344,288 |
Equity compensation plans not approved by stockholders |
|
— |
|
— |
|
— | |
|
5,151,816 |
|
|
1,344,288 |
• |
methods to account for significant unusual transactions; |
• |
the quality of the Centene’s accounting principles, including the effect of significant accounting policies in controversial or emerging areas; |
• |
the process used by management in formulating particularly sensitive accounting estimates, the reasonableness of significant judgments, and the basis for the conclusions of KPMG LLP regarding the reasonableness of those estimates; |
• |
disagreements with management over the application of accounting principles, the basis for management's accounting estimates and the disclosures in the financial statements; and |
• |
material weaknesses or significant internal control deficiencies, if any. |
• |
disclose in writing all relationships that in the auditor’s professional opinion may reasonably be thought to bear on independence; |
• |
confirm their perceived independence; and |
• |
engage in a discussion of independence. |
|
AUDIT COMMITTEE |
|
Steve Bartlett |
|
Frederick H. Eppinger |
|
John R. Roberts, Chair |
KPMG |
||||||||
2009 |
2008 |
|||||||
Audit Fees |
$ | 1,447 | $ | 1,350 | ||||
Audit-Related Fees |
97 | 112 | ||||||
Tax Fees |
— | — | ||||||
All Other Fees |
— | — |
|
COMPENSATION COMMITTEE |
|
Robert K. Ditmore, Chair |
|
Pamela A. Joseph |
|
David L. Steward |
|
Tommy G. Thompson |
· |
fall between the 50th percentile and 75th percentile of the 19 company insurance industry peer group (discussed below) based on size adjusted and compensation regressed organizations at revenues of $4 billion; |
· |
fall between the 50th percentile and 75th percentile of general industry organizations based on revenues of $4 billion; and |
· |
approximate the 50th percentile of organizations in the general industry that have similar growth and long-term performance as Centene based on revenues of $6 billion. |
· |
base salary to approximate the 75th percentile of similarly-sized organizations; |
· |
annual bonus target to approximate the 50th percentile of similarly-sized organizations; and |
· |
long-term incentives to approximate the 50th percentile of similarly-sized organizations. |
· |
Managed Health Care Companies (Centene classification) |
· |
Health Care Facilities |
· |
Health Care Services |
1. |
Aetna, Inc |
2. |
Amedisys Inc. |
3. |
Amerigroup Corporation * |
4. |
Catalyst Health Solutions, Inc. |
5. |
CIGNA Corporation |
6. |
Community Health Systems, Inc. |
7. |
Coventry Health Care, Inc. * |
8. |
Davita Inc. |
9. |
Health Net, Inc. |
10. |
Healthspring, Inc. |
11. |
Humana Inc. |
12. |
Lifepoint Hospitals, Inc. |
13. |
Magellan Health Services Inc. * |
14. |
Molina Healthcare, Inc. * |
15. |
Sun Healthcare Group Inc. |
16. |
UnitedHealth Group Incorporated |
17. |
Universal American Corporation |
18. |
Wellcare Health Plans, Inc. |
19. |
WellPoint, Inc. |
· |
5-year return on net assets > 10% |
· |
5-year sales growth > 10% |
· |
5-year earnings per share growth > 10% |
· |
5-year total shareholder return > 7% |
• |
the chief executive officer’s recommendations as to compensation for all other executive officers; |
• |
the scope of responsibility, experience, time in position and individual performance of each officer, including the chief executive officer; |
• |
the effectiveness of each executive’s leadership performance and potential to enhance long-term stockholder value; and |
• |
internal equity. |
• |
meeting the company’s earnings per share objective; |
• |
our overall performance, including our performance versus our business plan; |
• |
the performance of the individual officer including the effectiveness of each executive’s leadership performance and potential to enhance long-term stockholder value; |
• |
targeted bonus amounts which are based upon market data; and |
• |
the recommendation of the chief executive officer. |
• |
This keeps our total compensation opportunity in line with our competitive objectives (that is, not every component of pay can be positioned at the high end of the range, or else total compensation opportunity will exceed the high end of the range). |
• |
Our staffing model and business plan should provide, over a longer time horizon, opportunities for greater than average wealth accumulation as performance warrants. |
Named Executive Officer |
|
Minimum Ownership Requirement as a Percentage of Base Salary |
Chairman, President and Chief Executive Officer |
|
5X |
Executive Vice President |
|
2.5X |
Senior Vice President |
|
2X |
Plan & Specialty Company Presidents, Plan Chief Operating Officers, and Corporate Vice Presidents |
1X |
Name & Principal Position |
Year |
Salary
($) |
Bonus
($) |
Stock
Awards
($) 1 |
Option
Awards
($) 1 |
All Other
Compensation
($) |
Total
($) | |||||||||||||||
Michael F. Neidorff |
2009 |
$ |
1,000,000 |
$ |
1,750,000 |
$ |
2,878,500 |
$ |
— |
$ |
449,400 |
2 |
$ |
6,077,900 | ||||||||
Chairman, President and Chief Executive Officer |
2008 |
1,000,000 |
1,250,000 |
1,691,000 |
— |
418,365 |
4,359,365 | |||||||||||||||
2007 |
1,000,000 |
1,000,000 |
2,479,000 |
— |
477,224 |
4,956,224 | ||||||||||||||||
William N. Scheffel |
2009 |
595,000 |
575,000 |
474,500 |
— |
32,850 |
3 |
1,677,350 | ||||||||||||||
Executive Vice President and Chief Financial Officer |
2008 |
575,000 |
500,000 |
358,400 |
— |
27,750 |
1,461,150 | |||||||||||||||
2007 |
510,000 |
350,000 |
495,800 |
— |
26,362 |
1,382,162 | ||||||||||||||||
Mark W. Eggert |
2009 |
570,000 |
450,000 |
379,600 |
— |
22,898 |
4 |
1,422,498 | ||||||||||||||
Executive Vice President, Health Plan Business Unit |
2008 |
550,000 |
455,000 |
358,400 |
— |
18,424 |
1,381,824 | |||||||||||||||
Jason M. Harrold |
2009 |
328,077 |
315,288 |
469,100 |
45,637 |
65,656 |
5 |
1,223,758 | ||||||||||||||
Senior Vice President, Specialty Business Unit |
||||||||||||||||||||||
Jesse N. Hunter |
2009 |
425,000 |
375,000 |
474,500 |
— |
36,099 |
6 |
1,310,599 | ||||||||||||||
Executive Vice President, Corporate Development |
2008 |
391,154 |
400,000 |
621,800 |
83,805 |
29,636 |
1,526,395 | |||||||||||||||
2007 |
266,538 |
180,000 |
247,900 |
— |
8,156 |
702,594 | ||||||||||||||||
Eric R. Slusser |
2009 |
545,000 |
170,313 |
— |
— |
16,350 |
731,663 | |||||||||||||||
Former Executive Vice President and Chief Financial Officer |
2008 |
525,000 |
325,000 |
179,200 |
— |
267,205 |
1,296,405 | |||||||||||||||
2007 |
228,365 |
275,000 |
1,045,050 |
899,798 |
63,986 |
2,512,199 |
1 |
The amounts reported as Stock Awards and Option Awards reflect the fair value of grants made during the current year under the Company’s stock incentive plans. Assumptions used in the calculation of this amount for fiscal years ended December 31, 2009, 2008 and 2007 are included in footnote 16 to the Company’s
audited financial statements for the fiscal year ended December 31, 2009, included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 22, 2010. There can be no assurance that the grant date fair value of Stock Awards will ever be realized. |
2 |
All other compensation includes $232,800 of personal use of company provided aircraft. Pursuant to the policy established by our board, our Chairman, President and Chief Executive Officer is required to use company provided aircraft for all travel, a taxable benefit to Mr. Neidorff pursuant to the applicable Internal Revenue Service regulations.
For flights on corporate aircraft, aggregate incremental cost is calculated based on a cost-per-flight-hour charge developed by a nationally recognized and independent service. This flight-hour charge reflects the direct operating costs of the aircraft, including fuel, additives and lubricants, airport fees and assessments, as well as aircraft landing and parking, customs and permit fees, in-flight supplies and food, and flight planning and weather services. In addition, the flight-hour charge provides for periodic
engine and auxiliary power unit overhauling, outside labor and maintenance parts for the airframe, engine and avionics, crew travel expenses and other miscellaneous costs. The other amounts included in other compensation for Mr. Neidorff include $129,100 in life insurance benefits, $60,150 in nonqualified deferred compensation match, tax preparation and financial advisor fees, company entertainment event tickets and 401k match. |
3 |
All other compensation includes $25,500 in nonqualified deferred compensation match, tax preparation and financial advisor fees, security services, as well as life insurance benefits. |
4 |
All other compensation includes tax preparation and financial advisor fees, security services, as well as life insurance benefits. |
5 |
All other compensation includes $49,042 for relocation expenses as well as nonqualified deferred compensation match. |
6 |
All other compensation includes nonqualified deferred compensation match, tax preparation and financial advisor fees, transportation, life insurance benefits as well as security services. |
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards |
All Other Stock
Awards: Number
of Shares of Stock
or Units (#) 1 |
All Other Option
Awards:
Number of Securities Underlying
Options (#) 1 |
Exercise or Base
Price of Option
Awards ($/Sh) |
Closing Market Price on Date of Grant
($/Sh) |
||||||||||||||||||||
Name |
Grant Date |
Threshold
($) |
Target
($) |
Maximum
($) |
Grant Date
Fair Value ($) 2 | |||||||||||||||||||
Michael F. Neidorff |
12/11/2009 |
$ |
600,000 |
$ |
1,500,000 |
$ |
2,250,000 |
150,000 |
— |
$ |
— |
$ |
— |
$ |
2,878,500 | |||||||||
William N. Scheffel |
12/10/2009 |
238,000 |
595,000 |
892,500 |
25,000 |
— |
— |
— |
474,500 | |||||||||||||||
Mark W. Eggert |
12/10/2009 |
228,000 |
570,000 |
855,000 |
20,000 |
— |
— |
— |
379,600 | |||||||||||||||
Jason M. Harrold |
7/27/2009 |
— |
— |
— |
10,000 |
5,000 |
18.44 |
17.98 |
230,037 | |||||||||||||||
12/10/2009 |
96,000 |
240,000 |
360,000 |
15,000 |
— |
— |
— |
284,700 | ||||||||||||||||
Jesse N. Hunter |
12/10/2009 |
170,000 |
425,000 |
637,500 |
25,000 |
— |
— |
— |
474,500 |
1 |
All 2009 stock grants were made under the Company’s 2003 Stock Incentive Plan. The 2009 option grant was made under the Company’s 2000 Stock Incentive Plan. |
2 |
Assumptions used in the calculation of the Grant Date Fair Value are included in footnote 16 to the Company’s audited financial statements for the fiscal year ended December 31, 2009, included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 22, 2010. There
can be no assurance that the Grant Date Fair Value of Stock Awards will ever be realized. |
Name |
|
Option Awards |
|
Stock Awards | ||||||||||||
|
Number of Securities
Underlying
Unexercised Options
(# Exercisable) |
|
Number of
Securities
Underlying
Unexercised
Unearned Options
(# Unexercisable) |
Option Exercise Price 1 ($) |
|
Option Expiration Date |
|
Number of Shares or Units of
Stock That Have Not Vested (#) |
Market Value of Shares or
Units of Stock That Have Not Vested ($) | |||||||
Michael F. Neidorff |
|
10,210 |
|
— |
$ |
7.57 |
|
7/24/2012 |
|
400,000 |
2 |
$ |
8,468,000 | |||
|
244,036 |
|
— |
13.58 |
|
8/26/2013 |
|
33,333 |
3 |
705,660 | ||||||
|
200,000 |
|
— |
13.98 |
|
12/16/2013 |
|
100,000 |
4 |
2,117,000 | ||||||
|
180,000 |
|
— |
17.85 |
|
7/27/2014 |
|
150,000 |
5 |
3,175,500 | ||||||
|
200,000 |
|
— |
25.40 |
|
12/13/2015 |
|
— |
— | |||||||
|
100,000 |
|
— |
25.21 |
|
12/12/2016 |
|
— |
— | |||||||
William N. Scheffel |
|
28,486 |
|
— |
15.35 |
|
12/1/2013 |
|
7,000 |
9 |
148,190 | |||||
|
30,000 |
|
— |
16.65 |
|
5/4/2014 |
|
10,000 |
10 |
211,700 | ||||||
|
50,000 |
|
— |
26.07 |
|
12/8/2014 |
|
20,000 |
11 |
423,400 | ||||||
|
20,000 |
|
5,000 |
6 |
32.06 |
|
7/26/2015 |
|
25,000 |
12 |
529,250 | |||||
|
8,000 |
|
2,000 |
7 |
25.40 |
|
12/13/2015 |
|
— |
— | ||||||
|
6,000 |
|
4,000 |
8 |
25.21 |
|
12/12/2016 |
|
— |
— | ||||||
Mark W. Eggert |
30,000 |
45,000 |
13 |
22.23 |
11/13/2017 |
15,000 |
14 |
317,550 | ||||||||
— |
— |
— |
— |
5,000 |
10 |
105,850 | ||||||||||
— |
— |
— |
— |
20,000 |
11 |
423,400 | ||||||||||
— |
— |
— |
— |
20,000 |
12 |
423,400 | ||||||||||
Jason M. Harrold |
4,500 |
3,000 |
8 |
25.21 |
12/12/2016 |
1,000 |
17 |
21,170 | ||||||||
2,000 |
3,000 |
15 |
24.79 |
12/12/2017 |
2,200 |
18 |
46,574 | |||||||||
— |
5,000 |
16 |
18.44 |
7/27/2019 |
10,000 |
19 |
211,700 | |||||||||
15,000 |
12 |
317,550 | ||||||||||||||
Jesse N. Hunter |
3,000 |
— |
6.29 |
2/21/2012 |
500 |
21 |
10,585 | |||||||||
15,000 |
— |
13.58 |
8/26/2013 |
2,000 |
17 |
42,340 | ||||||||||
6,400 |
1,600 |
7 |
25.40 |
12/13/2015 |
3,500 |
22 |
74,095 | |||||||||
7,200 |
4,800 |
8 |
25.21 |
12/12/2016 |
5,000 |
10 |
105,850 | |||||||||
2,000 |
8,000 |
20 |
16.84 |
4/28/2018 |
30,000 |
11 |
635,100 | |||||||||
— |
— |
— |
— |
4,000 |
23 |
84,680 | ||||||||||
— |
— |
— |
— |
25,000 |
12 |
529,250 | ||||||||||
Eric R. Slusser |
— |
— |
— |
— |
3,333 |
24 |
70,560 |
1 |
The option price for each grant is equal to the previous day’s closing market price. |
2 |
The shares vest in five equal annual installments on November 8, 2010, 2011, 2012, 2013 and 2014. |
3 |
The shares vest on December 12, 2010. |
4 |
The shares vest in three equal installments on February 10, 2010, December 10, 2010, and December 10, 2011. |
5 |
The shares vest in three equal installments beginning on the anniversary of the grant date beginning on December 11, 2010. |
6 |
The options vest on July 26, 2010. |
7 |
The options vest on December 13, 2010. |
8 |
The options vest in two equal annual installments on the anniversary of the grant date beginning on December 12, 2010. |
9 |
1,000 shares vest on December 13, 2010; 6,000 shares vest in two equal annual installments on the anniversary of the grant date beginning on December 12, 2010. |
10 |
The shares vest in two equal installments on the anniversary of the grant date beginning on December 12, 2010. |
11 |
The shares vest in three equal installments on February 10, 2010, December 9, 2010, and December 9, 2011. |
12 |
The shares vest in three equal installments beginning on the anniversary of the grant date beginning on December 10, 2010. |
13 |
The options vest in three equal annual installments on the anniversary of the grant date beginning on November 13, 2010. |
14 |
The shares vest in three equal annual installments on the anniversary of the grant date beginning on November 13, 2010. |
15 |
The options vest in three equal annual installments on the anniversary of the grant date beginning on December 12, 2010. |
16 |
The options vest in five equal annual installments on the anniversary of the grant date beginning on July 27, 2010. |
17 |
The shares vest in two equal annual installments on the anniversary of the grant date beginning on December 12, 2010. |
18 |
The shares vest in four equal annual installments on the anniversary of the grant date beginning on December 9, 2010. |
19 |
The shares vest in five equal annual installments on the anniversary of the grant date beginning on July 27, 2010. |
20 |
The options vest in four equal annual installments on the anniversary of the grant date beginning on April 28, 2010. |
21 |
The shares vest on December 13, 2010. |
22 |
The shares vest on February 7, 2010. |
23 |
The shares vest in four equal annual installments on the anniversary of the grant date beginning April 28, 2010. |
24 |
The shares vest on February 10, 2010. |
Name |
|
Option Awards |
Stock Awards | ||||||||||
|
Number of Shares
Acquired on Exercise (#) |
Value Realized on
Exercise ($) |
|
Number of Shares
Acquired on Vesting (#) |
Value Realized on
Vesting ($) | ||||||||
Michael F. Neidorff |
|
10,000 |
$ |
14,600 |
666,667 |
1 |
$ |
12,903,675 | |||||
William N. Scheffel |
|
6,000 |
9,640 |
14,000 |
280,630 | ||||||||
Mark W. Eggert |
— |
— |
10,000 |
195,875 | |||||||||
Jason M. Harrold |
— |
— |
1,050 |
20,123 | |||||||||
Jesse N. Hunter |
|
— |
— |
11,000 |
219,915 | ||||||||
Eric R. Slusser |
|
— |
— |
15,000 |
299,900 |
1 |
Pursuant to the terms of the grant agreement, the receipt of 600,000 restricted stock units vesting during 2009 have been deferred until retirement. |
Name |
|
Executive
Contributions in
Last FY ($) 1 |
|
Registrant
Contributions in
Last FY ($) 2 |
|
Aggregate
Earnings (Losses)
in Last FY ($) 3 |
|
Aggregate
Withdrawals /
Distributions ($) |
Aggregate Balance
at Last FYE ($) 4 | |||||||
Michael F. Neidorff |
|
$ |
11,679,000 |
5 |
$ |
60,150 |
|
$ |
1,210,130 |
5 |
$ |
— |
$ |
13,437,516 5 | ||
William N. Scheffel |
|
65,014 |
|
25,500 |
|
(12,509) |
|
— |
237,311 | |||||||
Mark W. Eggert |
— |
— |
— |
— |
— | |||||||||||
Jason M. Harrold |
43,404 |
10,107 |
17,406 |
— |
76,598 | |||||||||||
Jesse N. Hunter |
49,010 |
17,400 |
18,144 |
— |
112,647 | |||||||||||
Eric R. Slusser |
32,700 |
7,990 |
8,766 |
— |
104,667 |
1 |
Executive contributions, with the exception of the contribution discussed in footnote 5, are included in the Salary column in the Summary Compensation Table. |
2 |
All registrant contributions are included in the Other Compensation column in the Summary Compensation Table. |
3 |
The company does not pay above market interest or preferential dividends on investments in the Deferred Compensation Plan. |
4 |
The Aggregate Balance at Last Fiscal Year-End column includes money the company owes these individuals for salaries and incentive compensation they earned in prior years but did not receive because they elected to defer receipt of it and save it for retirement. For |
|
fiscal 2009, the amounts described in footnote 1 are included in the Summary Compensation Table as described in footnote 1. For fiscal 2008, the following aggregate amounts of executive contributions were included in the Summary Compensation Table: Mr. Neidorff -$60,000; Mr. Scheffel -$55,500; Mr. Slusser-$31,500. For fiscal 2007, the following
aggregate amounts of executive contributions were included in the Summary Compensation Table: Mr. Neidorff -$60,000; Mr. Scheffel -$30,207; Mr. Slusser-$7,673. For prior years, all amounts contributed by a named executive officer in such years have been reported in the Summary Compensation Table in our previously filed proxy statements in the year earned, to the extent the executive was named in such proxy statements and the amounts were so required to be reported in such tables. |
5 |
Pursuant to the terms of the grant agreement, the receipt of 600,000 restricted stock units vesting during 2009 have been deferred until retirement. The fair market value at the time of vesting (executive contribution), increase in value during 2009 (aggregate earnings), and December 31, 2009 market value (balance at last FYE) are
presented in the table. Mr. Neidorff contributed $135,000 to the Company’s Deferred Compensation plan during 2009. |
Name |
|
Fees Earned or Paid
in Cash ($) |
|
Stock Awards ($) 1 |
|
Total ($) | |||
Steve Bartlett |
|
$ |
— |
|
$ |
225,000 |
|
$ |
225,000 |
Robert K. Ditmore |
|
— |
|
240,000 |
|
240,000 | |||
Frederick H. Eppinger |
|
— |
|
225,000 |
|
225,000 | |||
Richard A. Gephardt |
|
115,000 |
|
100,000 |
|
215,000 | |||
Pamela A. Joseph |
— |
225,000 |
225,000 | ||||||
John R. Roberts |
|
30,000 |
|
225,000 |
|
255,000 | |||
David L. Steward |
|
— |
|
240,000 |
240,000 | ||||
Tommy G. Thompson |
|
— |
|
240,000 |
|
240,000 |
1 |
The amounts reported as Stock Awards reflect the grant date fair value of grants made during the current year under the 2003 Stock Incentive Plan and Non-Employee Directors Deferred Stock Compensation Plan. Assumptions used in the calculation of this amount for fiscal years ended December 31, 2009, 2008 and 2007 are included
in footnote 16 to the Company’s audited financial statements for the fiscal year ended December 31, 2009 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 22, 2010. There can be no assurance that the grant date fair value of Stock Awards will ever be realized. |
Option Awards |
Stock Awards | ||||||||
Name |
|
Number of Securities Underlying Unexercised Options (# Exercisable) |
|
Number of Securities Underlying Unexercised Options (# Unexercisable) |
|
Number of Shares or Units of Stock That Have Not Vested (#) | |||
Steve Bartlett |
|
|
— |
|
|
— |
|
|
5,073 |
Robert K. Ditmore |
|
|
32,500 |
|
|
— |
|
|
5,073 |
Frederick H. Eppinger |
|
10,000 |
|
— |
|
5,073 | |||
Richard A. Gephardt |
|
10,000 |
|
— |
|
5,073 | |||
Pamela A. Joseph |
6,667 |
3,333 |
5,073 | ||||||
John R. Roberts |
|
11,000 |
|
4,000 |
|
5,073 | |||
David L. Steward |
|
25,000 |
|
— |
|
5,073 | |||
Tommy G. Thompson |
|
10,000 |
|
— |
|
5,073 |
• |
If any individual, entity or group (other than a group which includes the executive) acquires 40% or more of the voting power of our outstanding securities; |
• |
If a majority of the incumbent board of directors are replaced. For these purposes, the incumbent board of directors means the directors who were serving as of the effective date of the applicable executive agreement and any individual who becomes a director subsequent to such date whose election or nomination for election was approved by
a majority of such directors, other than in connection with a proxy contest; or |
• |
Upon the consummation of a merger or consolidation of the Company with another person, other than a merger or consolidation where the individuals and entities who were beneficial owners, respectively, of our outstanding voting securities immediately prior to such merger or consolidation own 50% or more of the then-outstanding shares of the
combined voting power of the then-outstanding voting securities of the corporation resulting from such merger or consolidation. |
Executive Benefits and
Payments Upon Terminations |
|
Voluntary
Termination |
|
Involuntary
Not for Cause
or Voluntary
with Good
Reason
Termination |
|
For Cause
Termination |
|
Retirement |
|
Death |
|
Disability |
|
Change in
Control | |||||||
Severance |
$ |
— |
|
$ |
7,500,000 |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
7,500,000 | |
Pro rata Bonus Payment |
— |
|
1,500,000 |
|
— |
|
— |
|
1,500,000 |
|
1,500,000 |
|
1,500,000 | ||||||||
Unvested Restricted Stock |
— |
|
14,466,160 |
|
— |
|
— |
|
14,466,160 |
|
14,466,160 |
|
14,466,160 | ||||||||
Long-term Incentive Plan Payment at Target |
— |
3,000,000 |
— |
3,000,000 |
3,000,000 |
3,000,000 |
3,000,000 | ||||||||||||||
Welfare Benefits Values |
— |
|
— |
|
— |
|
— |
|
5,000,000 |
|
— |
|
— | ||||||||
Excise Tax & Gross-Up |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
3,392,806 |
Executive Benefits and
Payments Upon Terminations |
Voluntary
Termination |
Involuntary
Not for Cause
Termination |
For Cause
Termination |
Death |
Disability |
Change in
Control | ||||||||||||
Severance |
$ |
— |
$ |
595,000 |
$ |
— |
$ |
— |
$ |
— |
$ |
2,040,000 | ||||||
Pro rata Bonus Payment |
— |
446,250 |
— |
— |
— |
446,250 | ||||||||||||
Unvested Restricted Stock |
— |
649,199 |
— |
— |
— |
1,312,540 | ||||||||||||
Long-term Incentive Plan Payment at Target |
— |
— |
— |
1,085,000 |
1,085,000 |
1,085,000 | ||||||||||||
Welfare Benefits Values |
— |
17,395 |
— |
550,000 |
— |
111,573 | ||||||||||||
Outplacement |
— |
10,000 |
— |
— |
— |
10,000 | ||||||||||||
Excise Tax & Gross-Up |
— |
— |
— |
— |
— |
1,630,226 |
Executive Benefits and
Payments Upon Terminations |
Voluntary
Termination |
Involuntary
Not for Cause
Termination |
For Cause
Termination |
Death |
Disability |
Change in
Control | ||||||||||||
Severance |
$ |
— |
$ |
570,000 |
$ |
— |
$ |
— |
$ |
— |
$ |
1,965,000 | ||||||
Pro rata Bonus Payment |
— |
427,500 |
— |
— |
— |
427,500 | ||||||||||||
Unvested Restricted Stock |
— |
582,175 |
— |
— |
— |
1,270,200 | ||||||||||||
Long-term Incentive Plan Payment at Target |
— |
— |
— |
1,100,000 |
1,100,000 |
1,100,000 | ||||||||||||
Welfare Benefits Values |
— |
17,395 |
— |
500,000 |
— |
130,159 | ||||||||||||
Outplacement |
— |
10,000 |
— |
— |
— |
10,000 | ||||||||||||
Excise Tax & Gross-Up |
— |
— |
— |
— |
— |
1,572,100 |
Executive Benefits and
Payments Upon Terminations |
Voluntary
Termination |
Involuntary
Not for Cause
Termination |
For Cause
Termination |
Death |
Disability |
Change in
Control | ||||||||||||
Severance |
$ |
— |
$ |
400,000 |
$ |
— |
$ |
— |
$ |
— |
$ |
965,000 | ||||||
Pro rata Bonus Payment |
— |
160,000 |
— |
— |
— |
160,000 | ||||||||||||
Unvested Stock Option Spread |
— |
2,730 |
— |
— |
— |
13,650 | ||||||||||||
Unvested Restricted Stock |
— |
170,419 |
— |
— |
— |
596,994 | ||||||||||||
Welfare Benefits Values |
— |
16,470 |
— |
1,100,000 |
— |
187,823 | ||||||||||||
Outplacement |
— |
10,000 |
— |
— |
— |
10,000 | ||||||||||||
Excise Tax & Gross-Up |
— |
— |
— |
— |
— |
584,574 |
Executive Benefits and
Payments Upon Terminations |
Voluntary
Termination |
Involuntary
Not for Cause
Termination |
For Cause
Termination |
Death |
Disability |
Change in
Control | ||||||||||||
Severance |
$ |
— |
$ |
425,000 |
$ |
— |
$ |
— |
$ |
— |
$ |
1,430,000 | ||||||
Pro rata Bonus Payment |
— |
318,750 |
— |
— |
— |
318,750 | ||||||||||||
Unvested Stock Option Spread |
— |
8,660 |
— |
— |
— |
34,640 | ||||||||||||
Unvested Restricted Stock |
— |
779,755 |
— |
— |
— |
1,481,900 | ||||||||||||
Long-term Incentive Plan Payment at Target |
— |
— |
— |
580,000 |
580,000 |
580,000 | ||||||||||||
Welfare Benefits Values |
— |
17,395 |
— |
1,450,000 |
— |
163,944 | ||||||||||||
Outplacement |
— |
10,000 |
— |
— |
— |
10,000 | ||||||||||||
Excise Tax & Gross-Up |
— |
— |
— |
— |
— |
1,347,289 |
• |
each person, entity or group of affiliated persons or entities known by us to beneficially own more than 5% of our outstanding common stock; |
• |
each of our Named Executive Officers, directors (two of whom are nominated for re-election); and |
• |
all of our executive officers and directors as a group. |
Beneficial Ownership |
||||||||||||
Name and Address of Beneficial Owner |
Outstanding
Shares |
Shares
Acquirable
Within 60 Days |
Total
Beneficial
Ownership |
Percent
Ownership |
Shares Not
Acquirable
Within 60 Days1 | |||||||
T. Rowe Price Associates, Inc. |
3,843,300 |
— |
3,843,300 |
7.8 |
— | |||||||
100 East Pratt Street
Baltimore, Maryland 21202 |
||||||||||||
FMR LLC |
3,513,280 |
— |
3,513,280 |
7.2 |
— | |||||||
82 Devonshire Street
Boston, Massachusetts 02109 |
||||||||||||
BlackRock, Inc. |
3,368,621 |
— |
3,368,621 |
6.9 |
— | |||||||
55 East 52nd Street
New York, New York 10055 |
||||||||||||
Lord, Abbett & Co. LLC |
3,172,575 |
— |
3,172,575 |
6.5 |
— | |||||||
90 Hudson Street, 11th floor
Jersey City, NJ 07302 |
||||||||||||
Michael F. Neidorff |
281,234 |
1,534,246 |
2 |
1,815,480 |
2 |
3.6 |
690,904 | |||||
Robert K. Ditmore |
345,331 |
3 |
64,033 |
409,364 |
4 |
* |
— | |||||
William N. Scheffel |
55,821 |
142,486 |
198,307 |
* |
66,334 | |||||||
David L. Steward |
19,541 |
56,533 |
76,074 |
4 |
* |
— | ||||||
John R. Roberts |
25,541 |
5 |
42,948 |
68,489 |
4 |
* |
4,000 | |||||
Steve Bartlett |
28,341 |
29,544 |
57,885 |
4 |
* |
— | ||||||
Tommy G. Thompson |
17,041 |
39,301 |
56,342 |
4 |
* |
— | ||||||
Jesse N. Hunter |
21,534 |
33,600 |
55,134 |
* |
70,900 | |||||||
Frederick H. Eppinger |
12,960 |
35,588 |
48,548 |
4 |
* |
— | ||||||
Mark W. Eggert |
14,632 |
30,000 |
44,632 |
* |
98,334 | |||||||
Pamela A. Joseph |
14,722 |
25,500 |
40,222 |
4 |
* |
3,333 | ||||||
Richard A. Gephardt |
13,270 |
15,073 |
28,343 |
* |
— | |||||||
Eric R. Slusser |
17,382 |
— |
17,382 |
* |
— | |||||||
Jason M. Harrold |
1,367 |
6,500 |
7,867 |
* |
39,507 | |||||||
All directors and executive officers as a group (21 persons) |
938,186 |
2,168,844 |
3,107,030 |
6.1 |
1,237,749 |
* |
Represents less than 1% of outstanding shares of common stock. |
1 |
The share numbers in the column labeled “Shares Not Acquirable Within 60 Days” reflect the number of shares underlying options and restricted stock units which are unvested and will not vest within 60 days of February 26, 2010. The share numbers also include the number of phantom shares acquired through the Company’s deferred
compensation plan. Those shares are not considered to be beneficially owned under the rules of the SEC. |
2 |
Of Mr. Neidorff’s shares acquirable within 60 days, 600,000 were granted in the form of restricted stock units, payable in shares of common stock, pursuant to the executive employment agreement with Mr. Neidorff dated November 8, 2004. The shares vested in November 2009. The restricted stock units shall be distributed
to Mr. Neidorff on the later of (a) January 15 of the first calendar year following |
termination of Mr. Neidorff’s employment and (b) the date that is six months after Mr. Neidorff’s “separation of service” as defined in the Internal Revenue Code. | |
3 |
Mr. Ditmore’s outstanding shares include 80,050 shares owned by family members, family partnerships or trusts. Mr. Ditmore disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
4 |
Shares beneficially owned by Messrs. Bartlett, Ditmore, Eppinger, Roberts, Steward, Thompson and Ms. Joseph include 24,471, 26,460, 20,515, 26,875, 26,460, 24,228 and 13,760, respectively, restricted stock units acquired through the Non-Employee Directors Deferred Stock Compensation Plan. |
5 |
Mr. Roberts’ outstanding shares include 20,541 shares owned by a revocable trust. Mr. Roberts disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
|
(a) |
Administration by Board of Directors. The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable, provided that awards to a director may only
be recommended by a committee comprised solely of independent directors and approved only by all independent directors of the board. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency. All decisions by the Board shall be made in the Board’s sole discretion and shall be final and binding on all persons
having or claiming any interest in the Plan or in any Award. No director or person acting pursuant to the authority delegated by the Board shall be liable for any action or determination relating to or under the Plan made in good faith. |
|
(b) |
Appointment of Committees. To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (a “Committee”). All references in the Plan to the “Board” shall mean the Board or a Committee of the Board or the executive officers referred to
in Section 3(c) to the extent that the Board’s powers or authority under the Plan have been delegated to such Committee or executive officers. |
|
(c) |
Delegation to Executive Officers. To the extent permitted by applicable law, the Board may delegate to one or more executive officers of the Company the power to grant Awards to employees or officers of the Company or any of its present or future subsidiary corporations and to exercise such other powers under the Plan as the Board may determine, provided that
the Board shall fix the terms of the Awards to be granted by such executive officers (including the exercise price of such Awards, which may include a formula by which the exercise price will be determined) and the maximum number of shares subject to Awards that the executive officers may grant; provided further, however, that no executive officer shall be authorized to grant Awards to any “executive officer” of the Company, as |
|
defined by Rule 3b-7 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or to any “officer” of the Company (as defined by Rule 16a-1 under the Exchange Act). |
|
(a) |
Number of Shares. Subject to adjustment under Section 7, Awards may be made under the Plan for up to 9,050,000 shares of common stock, $.001 par value per share, of the Company (“Common Stock”). For purposes of counting the number of shares available for the grant of Awards under the Plan, |
|
(1) |
shares of Common Stock covered by independent SARs (as hereinafter defined) shall be counted against the number of shares available for the grant of Awards under the Plan; provided that independent SARs that may be settled in cash only shall not be so counted; |
|
(2) |
if any Award (A) expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right) or (B) results in any Common Stock not being issued (including as a result of an independent SAR
that was settleable either in cash or in stock actually being settled in cash), the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan; provided, however, in the case of Incentive Stock Options (as hereinafter defined), the foregoing shall be subject to any limitations under the Code; and |
|
(3) |
shares of Common Stock tendered to the Company by a Participant to (A) purchase shares of Common Stock upon the exercise of an Award or (B) satisfy tax withholding obligations (including shares retained from the Award creating the tax obligation) shall not be added back to the number of shares available for the future grant of Awards under the Plan. Shares issued under the Plan may consist in whole or in part of
authorized but unissued shares or treasury shares. |
|
(b) |
Sub-limits. Subject to adjustment under Section 8, the following sub-limits on the number of shares subject to Awards shall apply: |
|
(1) |
Per-Participant Limit. The maximum number of shares of Common Stock with respect to which Awards may be granted to any Participant under the Plan shall be 1,500,000 per calendar year. For purposes of the foregoing limit, the combination of an Option in tandem with a SAR shall be treated as a single Award. The per-Participant limit described in this Section
4(b)(1) shall be construed and applied consistently with Section 162(m) of the Code or any successor provision thereto (“Section 162(m)”). |
|
(a) |
General. The Board may grant options to purchase Common Stock (each, an “Option”) and determine the number of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable federal or state securities
laws, as it considers necessary or advisable. An Option that is not intended to be an Incentive Stock Option (as hereinafter defined) shall be designated a “Nonstatutory Stock Option.” |
|
(b) |
Incentive Stock Options. An Option that the Board intends to be an “incentive stock option” as defined in Section 422 of the Code (an “Incentive Stock Option”) shall only be granted to employees of Centene Corporation, any of Centene Corporation’s present or future parent or subsidiary corporations as defined in Sections 424(e)
or (f) of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently with the requirements of Section 422 of the Code. The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option. |
|
(c) |
Exercise Price. The Board shall establish the exercise price at the time each Option is granted and specify it in the applicable option agreement, provided, however, that the exercise price shall be not less than 100% of the fair market value of the Common Stock, as determined by the Board, at the time
the Option is granted. |
|
(d) |
Duration of Options. Each Option shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable option agreement, provided, however, that no Option will be granted for a term in excess of 10 years. |
|
(e) |
Exercise of Option. Options may be exercised by delivery to the Company of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board together with payment in full as specified in Section 5(f) for the number of shares for which the Option is exercised. |
|
(f) |
Payment Upon Exercise. Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as follows: |
|
(1) |
in cash or by check, payable to the order of the Company; |
|
(2) |
except as the Board may, in its sole discretion, otherwise provide in an option agreement, by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy
broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding; |
|
(3) |
when the Common Stock is registered under the Exchange Act, by delivery of shares of Common Stock owned by the Participant valued at their fair market value as determined by (or in a manner approved by) the Board in good faith (“Fair Market Value”), provided (i) such method of payment is then permitted under applicable law and (ii) such Common Stock, if acquired directly from the Company was owned by
the Participant at least six months prior to such delivery; |
|
(4) |
such other lawful consideration as the Board may determine in its sole discretion, provided that (i) at least an amount equal to the par value of the Common Stock being purchased shall be paid in cash and (ii) no such consideration shall consist in whole or in part of a promissory note or other evidence of indebtedness; or |
|
(5) |
by any combination of the above permitted forms of payment. |
|
(g) |
Substitute Options. In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or stock of an entity, the Board may grant Options in substitution for any options or other stock or stock-based Awards granted by such entity or an affiliate thereof. Substitute Options may be granted on such terms as
the Board deems appropriate in the circumstances, notwithstanding any limitations on Options contained in the other sections of this Section 5 or in Section 2. |
|
(a) |
Grants. The Board may grant Awards entitling recipients to acquire shares of Common Stock (“Restricted Stock”), subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event that conditions
specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. Instead of granting Awards for Restricted Stock, the Board may grant Awards entitling the recipient to receive shares of Common Stock to be delivered in the future (“Restricted Stock Units”) subject to such terms and conditions on the delivery of the shares of Common Stock as the Board shall determine (each Award for Restricted Stock
or Restricted Stock Units, a “Restricted Stock Award”). The Board may also permit an exchange of unvested shares of Common Stock that have |
|
already been delivered to a Participant for an instrument evidencing the right to future delivery of Common Stock at such time or times, and on such conditions, as the Board shall specify. |
|
(b) |
Terms and Conditions. |
|
(1) |
The Board shall determine the terms and conditions of any such Restricted Stock Award, including the conditions for repurchase (or forfeiture) and the issue price, if any. |
|
(2) |
If the Board determines to grant any Restricted Stock Awards designed to satisfy the requirements of Section 162(m)(4)(C) of the Code with respect to remuneration payable to a covered employee as defined in Section 162(m)(3) of the Code (“Covered Employee”) solely on account of one or more performance goals (“Performance Goals”) to be achieved during a performance period (“Performance
Period”), the following requirements shall apply: |
|
(A) |
A Committee consisting of two or more outside directors: |
|
(i) |
who are not current employees of the Company or any subsidiary or affiliate of the Company, |
|
(ii) |
who are not former employees of the Company or any subsidiary or affiliate of the Company who receive compensation for prior services (other than benefits under a tax-qualified retirement plan) from the Company or any subsidiary or affiliate of the Company during the taxable year, |
|
(iii) |
who have not been officers of the Company or a subsidiary or affiliate of the Company, and |
|
(iv) |
who do not receive direct or indirect compensation from the Company or any subsidiary or affiliate of the Company in any capacity other than as a director, |
|
shall determine and administer the grants provided for under this Section 6(b)(2). |
|
(B) |
(i) |
The Performance Goals upon which the payment or vesting of an Award to a Covered Employee pursuant to this Section 6(b)(2) shall be limited to the following performance measures (“Performance Measures”): |
|
(a) |
net earnings or net income (before or after taxes), |
|
(b) |
earnings per share, |
|
(c) |
net sales or revenue growth, |
|
(d) |
net operating profit, |
|
(e) |
return measures (including, but not limited to, return on assets, capital, invested capital, equity, sales, or revenue), |
|
(f) |
cash flow (including, but not limited to, operating cash flow, free cash flow, cash flow return on equity, and cash flow return on investment), |
|
(g) |
earnings before or after taxes, interest, depreciation, and/or amortization, |
|
(h) |
gross or operating margins, |
|
(i) |
productivity ratios, |
|
(j) |
share price (including, but not limited to, growth measures and total shareholder return), |
|
(k) |
expense targets, |
|
(l) |
margins, |
|
(m) |
operating efficiency, |
|
(n) |
market share, |
|
(o) |
customer satisfaction, |
|
(p) |
working capital targets, and |
|
(q) |
economic value added or EVA® (net operating profit after tax minus the sum of capital multiplied by the cost of capital). |
|
(ii) |
As the Committee may deem appropriate: |
|
(a) |
any of the foregoing Performance Measure(s) may be used to measure the performance of the Company, a subsidiary, and/or affiliate of the Company as a whole or any business unit of the Company, subsidiary, and/or affiliate or any combination thereof during the Performance Period; |
|
(b) |
any of the foregoing Performance Measures may be used to compare the performance of the Company, a subsidiary and/or affiliate of the Company as a whole or any business unit of the Company, subsidiary and/or affiliate to the performance of a group of comparator companies, or published or special index that the Committee, in its sole discretion, deems appropriate; |
|
(c) |
the Committee may select Performance Measure (j) above as compared to various stock market indices; and |
|
(d) |
the Committee shall have authority to provide for accelerated vesting of any Award based on the achievement of Performance Goals pursuant to the foregoing Performance Measures. |
|
|
(iii) |
The Committee may provide in any such Award that any evaluation of performance may include or exclude any of the following events that occurs during a Performance Period: |
|
(a) |
asset write-downs, |
|
(b) |
litigation or claim judgments or settlements, |
|
(c) |
the effect of changes in tax laws, accounting principles, or other laws or provisions affecting reported results, |
|
(d) |
any reorganization and restructuring programs, |
|
(e) |
extraordinary nonrecurring items as described in Accounting Principles Board Opinion No. 30 and/or in management’s discussion and analysis of financial condition and results of operations appearing in the Company’s annual report to shareholders for the applicable year, |
|
(f) |
acquisitions or divestitures, and |
|
(g) |
foreign exchange gains and losses. |
|
(C) |
The Performance Period for any Award pursuant to this Section 6(b)(2) shall not be less than one taxable year of the Company. |
|
(D) |
The maximum number of shares the Committee may grant to a Covered Employee during a taxable year of the Company pursuant to this Section 6(b)(2) shall be 1,000,000 shares. |
|
(E) |
The Performance Goals for any Award pursuant to this Section 6(b)(2) shall be memorialized in writing and furnished to affected Covered Employees not later than 90 days after the beginning of the Performance Period to which they apply. |
|
(F) |
The Committee shall certify in writing the accomplishment of the Performance Goals related to an Award before the Award can become unconditional. |
|
(G) |
Awards that are intended to qualify as Performance-Based Compensation may not be adjusted upward. The Committee shall retain the discretion to adjust such Awards downward, either on a formula or discretionary basis or any combination, as the Committee determines. |
|
(H) |
In the event that applicable tax and/or securities laws change to permit Committee discretion to alter the governing Performance Measures without obtaining shareholder approval of such changes, the Committee shall have sole discretion to make such changes without obtaining shareholder approval, provided the exercise of such discretion does not violate Code Section 409A. In addition, in the event that the Committee
determines that it is advisable to grant Awards that shall not qualify as Performance-Based Compensation, the Committee may make such grants without satisfying the requirements of Code Section 162(m) and base vesting on Performance Measures other than those set forth in this Section 6(b)(2). |
|
(I) |
This Section 6(b)(2) is designed to comply with the requirements of Section 162(m)(4)(C) of the Code and regulations issued thereunder and all provisions of this Section 6(b)(2) shall be applied consistent therewith. |
|
(c) |
Stock Certificates. Any stock certificates issued in respect of a Restricted Stock Award, if applicable, shall be registered in the name of the Participant and, unless otherwise determined by the Board, deposited by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction
periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant’s death (the “Designated Beneficiary”). In the absence of an effective designation by a Participant, Designated Beneficiary shall mean the Participant’s
estate. |
|
(a) |
General. A Stock Appreciation Right (“SAR”) is an Award entitling the holder, upon exercise, to receive an amount in Common Stock determined by reference to appreciation, from and after the date of grant, in the fair market value of a share of Common Stock. The date as of which such appreciation or other measure is determined shall be the exercise
date. |
|
(b) |
Grants. SARs may be granted in tandem with, or independently of, Options granted under the Plan. The Board shall establish the exercise price at the time each SAR is granted and specify it in the applicable SAR agreement, provided, however, that the exercise price shall be not less than 100% of the fair market value of the Common Stock, as determined by the
Board, at the time the SAR is granted. |
|
(1) |
Tandem Awards. When SARs are expressly granted in tandem with Options, (i) the SAR will be exercisable only at such time or times, and to the extent, that the related Option is exercisable (except to the extent designated by the Board in connection with a Reorganization Event) and will be exercisable in accordance with the procedure required for exercise of
the related Option; (ii) the SAR will terminate and no longer be exercisable upon the termination or exercise of the related Option, except to the extent designated by the Board in connection with a Reorganization Event and except that a SAR granted with respect to less than the full number of shares covered by an Option will not be reduced until the number of shares as to which the related Option has been exercised or has terminated exceeds the number of shares not covered by the SAR; (iii) the Option will terminate
and no longer be exercisable upon the exercise of the related SAR; and (iv) the SAR will be transferable only with the related Option. |
|
(2) |
Independent SARs. A SAR not expressly granted in tandem with an Option will become exercisable at such time or times, and on such conditions, as the Board may specify in the SAR Award. |
|
(c) |
Exercise. SARs may be exercised by delivery to the Company of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board, together with any other documents required by the Board. |
|
(a) |
Changes in Capitalization. In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any distribution to holders of Common Stock other than a normal cash dividend, (i) the number and class of securities available under
the Plan, (ii) the per-Participant limit set forth in Section 4(b), (iii) the number and class of securities and exercise price per share subject to each outstanding Option, and (iv) the repurchase price per share subject to each outstanding Restricted Stock Award shall be appropriately adjusted by the Company (or substituted Awards may be made, if applicable) to the extent the Board shall determine, in good faith, that such an adjustment (or substitution) is necessary and appropriate. If this Section 8(a) applies
and Section 8(c) also applies to any event, Section 8(c) shall be applicable to such event, and this Section 8(a) shall not be applicable. |
|
(b) |
Liquidation or Dissolution. In the event of a proposed liquidation or dissolution of the Company, the Board shall upon written notice to the Participants provide that all then unexercised Options will (i) become exercisable in full as of a specified time at least 10 business days prior to the effective date of such liquidation or dissolution and (ii) terminate
effective upon such liquidation or dissolution, except to the extent exercised before such effective date. The Board may specify the effect of a liquidation or dissolution on any Restricted Stock Award granted under the Plan at the time of the grant. |
|
(c) |
Reorganization Events. |
|
(1) |
Definition. A “Reorganization Event” shall mean: (a) any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or (b) any exchange of all of the Common Stock of the Company for cash,
securities or other property pursuant to a share exchange transaction. |
|
(2) |
Consequences of a Reorganization Event on Options. Upon the occurrence of a Reorganization Event,the Board shall provide that all outstanding Options shall be assumed, or equivalent options shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof). For purposes hereof, an Option shall be considered to be assumed if, following
consummation of the Reorganization Event, the Option confers the right to purchase, for each share of Common Stock subject to the Option immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration
chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the
exercise of Options to consist solely of common stock of the acquiring or succeeding corporation (or an affiliate thereof) equivalent in fair market value to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event. |
|
(3) |
Consequences of a Reorganization Event on Restricted Stock Awards. Upon the occurrence of a Reorganization Event, the repurchase and other rights of the Company under each outstanding Restricted Stock Award shall inure to the benefit of the Company’s successor and shall apply to the cash, securities or other property that the Common Stock was converted into or exchanged for pursuant to such Reorganization Event
in the same manner and to the same extent as they applied to the Common Stock subject to such Restricted Stock Award. |
|
(a) |
Transferability of Awards. Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an Incentive Stock Option, pursuant to a qualified domestic relations order, and, during
the life of the Participant, shall be exercisable only by the Participant; provided that the Board may permit or provide in an Award for the gratuitous transfer of the Award by the Participant to or for the benefit of any immediate family member, family trust or family partnership established solely for the benefit of the Participant and/or an immediate family member thereof if, with respect to such proposed transferee, the Company would be eligible to
use a registration statement on Form S-8 for the registration of the sale of the Common Stock subject to such Award under the Securities Act of 1933, as amended and provided further that the Company shall not be required to recognize any such transfer until such time as the Participant and such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument in form and substance satisfactory to the Company confirming
that such transferee shall be bound by all of the terms and conditions of the Award. References to a Participant, to the extent relevant in the context, shall include references to authorized transferees. |
|
(b) |
Documentation. Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in the Plan. |
|
(c) |
Board Discretion. Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly. |
|
(d) |
Termination of Status. The Board shall determine the effect on an Award of the disability, death, retirement, authorized leave of absence or other change in the employment or other status of a |
|
|
Participant and the extent to which, and the period during which, the Participant, the Participant’s legal representative, conservator, guardian or Designated Beneficiary may exercise rights under the Award. |
|
(e) |
Withholding. Each Participant shall pay to the Company, or make provision satisfactory to the Board for payment of, any taxes required by law to be withheld in connection with Awards to such Participant no later than the date of the event creating the tax liability. Except as the Board may otherwise provide in an Award, when the Common Stock is registered under
the Exchange Act, Participants may satisfy such tax obligations in whole or in part by delivery of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value; provided, however, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company’s minimum statutory withholding obligations (based on minimum statutory withholding rates
for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income). The Company may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to a Participant. |
|
(f) |
Amendment of Award. The Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting therefore another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option, provided that
the Participant’s consent to such action shall be required unless the Board determines that the action, taking into account any related action, would not materially and adversely affect the Participant, and would not cause adverse tax consequences to the Participant under Section 409A of the Code. |
|
(g) |
Conditions on Delivery of Stock. The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan or to remove restrictions from shares previously delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the opinion of the Company’s counsel, all other
legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and any applicable stock exchange or stock market rules and regulations, and (iii) the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations. |
|
(h) |
Vesting of Awards. No Award granted under the Plan after July 19, 2005 to any employee of the Company may vest or become exercisable in increments greater than one-third of the total Award in any period of twelve consecutive months following the date of grant. |
|
(i) |
Repricing of Awards. Unless such action is approved by the Company’s stockholders and does not cause an Award to become subject to Section 409A of the Code: (1) no outstanding Award granted under the Plan may be amended to provide for an exercise price per share that is less than the then-existing exercise price per share of such outstanding Award (other
than adjustments pursuant to Section 8), (2) the Board may not cancel any outstanding Award (whether or not granted under the Plan) and grant in substitution therefore new Awards under the Plan covering the same or a different number of shares of Common Stock and having an exercise price per share less than the then-existing exercise price per share of the cancelled Award, and (3) the Board may not repurchase any outstanding Award granted under the Plan at a price greater than the current fair market value of
the existing award. The terms of outstanding awards may not be amended to reduce the exercise price of outstanding Options or SARs or cancel, exchange, substitute, buyout or surrender outstanding Options or SARS in exchange for cash, other awards or Options or SARs with an exercise price that is less than the exercise price of the original Options or SARs without stockholder approval. |
|
(a) |
No Right To Employment or Other Status. No person shall have any claim or right to be granted an Award, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at |
|
|
any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. |
|
(b) |
No Rights As Stockholder. Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder of such shares. Notwithstanding the foregoing, in the event the Company effects a split
of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to such Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding
the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend. |
|
(c) |
Effective Date and Term of Plan. The Plan shall become effective on the date on which it is adopted by the Board, but no Award granted to a Participant that is intended to comply with Section 162(m) shall become exercisable, vested or realizable, as applicable to such Award, unless and until the Plan has been approved by the Company’s stockholders to
the extent stockholder approval is required by Section 162(m) in the manner required under Section 162(m), including the vote required under Section 162(m). No Awards shall be granted under the Plan after the completion of ten years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company’s stockholders, but Awards previously granted may extend beyond that date. |
|
(d) |
Amendment of Plan. The Board may amend, suspend or terminate the Plan or any portion thereof at any time, provided that (i) any “material revision” to the Plan (as defined in the New York Stock Exchange Listed Company Manual) must be approved by the Company’s stockholders prior to such
revision becoming effective and (ii) to the extent required by Section 162(m), no Award granted to a Participant that is intended to comply with Section 162(m) after the date of such amendment shall become exercisable, realizable or vested, as applicable to such Award, unless and until such amendment shall have been approved by the Company’s stockholders if required by Section 162(m), including the vote required under Section 162(m). |
|
(e) |
Governing Law. The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of the State of Delaware, without regard to any applicable conflicts of law. |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
AmerisourceBergen Corporation | ABC |
Marsh & McLennan Companies, Inc. | MMC |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|